Top RX group vs CVP

I think it is pretty clear that the CVP generalist program is considered as elite as any group out there from a pure M&A perspective both in terms of prestige and experience. they absolutely killed it in 2023 and appear to be continuing that trend this year. Also, being a generalist will give you the opportunity to figure out what sector you are most interested in - having the opportunity to work in HC, consumer, industrials, FIG, etc. is pretty valuable imo. RX will give you great technical training but the work itself is slightly niche. Obviously those RX groups (specifically EVR and HL not sure about Lazard) place super well but Centerview's exits are misrepresented on this forum. You will 100% be able to get ANY PE interview you want as a Centerview analyst and at that point it just comes down to you as a candidate. the reason why you don't see as many traditional mega fund exits from Centerview is because 1. they have a way higher A2A retention rate than other firms 2. their analysts don't do on-cycle until after their 1st year and at that point a lot of kids are disenchanted with finance and realize they'd rather do something else. Also, worth noting that doing on-cycle after your first year will make you a way way more prepared candidate (much more polished, have deal experience, etc). Either way these are all great options. good luck with your decision.